1548 KYG3825B1059

Rapport

Vertraagde tijd Hong Kong Stock Exchange - 09:08:49 03-02-2023
27.30	HKD		-4.21%

30/01	Genscript Biotech's Fase 3 studie voor Myeloma behandeling bereikt primair eindpunt; aandelen dalen met 4%	MT
18/01	GenScript ProBio, gesteund door Hillhouse, haalt $224 miljoen op bij Legend Capital en anderen	MR
03/01	Chinese toezichthouder aanvaardt Genscript Biotechs nieuwe geneesmiddelenaanvraag voor chimere antigen receptor; aandelen stijgen met 6%.	MT

Nieuws

Persberichten

Officiële publicaties

Sectornieuws

Communiqués de presse de la société GENSCRIPT BIOTECH CORPORATION

2022	Cell and Gene Therapy Companies Leverage GenScript's cGMP sgRNA Capability to Accelerat..	PR
2022	GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS	AQ
2022	GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identifica..	PR
2022	Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will furth..	AQ
2022	GenScript Named a BioSpace 2023 Best Place to Work	PR
2022	GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreak..	PR
2022	GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Proce..	PR
2022	GenScript USA Responds to Monkeypox Public-Health Emergency with Real-Time PCR Test	PR
2022	GenScript Launches Expedited mRNA Service for Research and Pre-Clinical Applications	PR
2022	GenScript to Host 2nd Annual Gene & Cell Engineering Virtual Summit	PR
2022	GenScript USA Enters Distribution Agreement with EUROIMMUN US for cPass SARS-CoV-2 Neut..	PR
2022	GenScript Debuts Industry's Highest Throughput DNA Synthesis Platform for Commercial DN..	PR
2021	Genscript Biotech : Launches Closed-End Double-Stranded DNA Service for CRISPR	PU
2021	GenScript Launches Closed-End Double-Stranded DNA Service for CRISPR	PR
2021	Genscript Biotech : Reports First Half 2021 Results	PR
2021	Genscript Biotech : Reports 2021 Interim Financial Results	PR
2021	Discloseable Transactions : Deemed disposal of equity interest in probio cayman	PU
2021	Genscript : to Host Gene & Cell Engineering Virtual Summit	PR
2021	Genscript Biotech : Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Ap..	PU
2021	Genscript : Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreeme..	PR
2021	Overseas Regulatory Announcement : The entry into a subscription agreement for sale of ord..	PU
2021	Genscript Biotech : Issue of new shares under general mandate	PU
2021	Inside Information : Disposal of shares by a controlling shareholder	PU
2021	Discloseable Transactions : (1) binding term sheet in relation to the proposed financing o..	PU
2021	Genscript Biotech : Trading halt	PU
2021	Genscript Biotech : Exchange notice - trading halt	PU
2021	Genscript Biotech : Voluntary announcement-research and development update	PU
2021	Genscript : Launches Research-Grade Lentiviral Vector Packaging Service	PR
2021	Genscript Biotech : Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate..	PU
2021	Genscript Biotech : Overseas regulatory announcement annual report for the year ended 31 d..	PU
2021	Genscript Biotech : Grant of share options and restricted shares	PU
2021	Genscript Biotech : Reports Full Year 2020 Financial Results and Business Results	PR
2021	Genscript Biotech : Reports Full Year 2020 Financial Results	PR
2021	Genscript Biotech : receives "Best Contract Research Organization Award" IN the 4th Annual..	PU
2021	Genscript : Submits Application with FDA for Use of cPass™ SARS-CoV-2 Neutralization..	PR
2020	Genscript : Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutrali..	PR
2020	Genscript Biotech : Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 ..	PU
2020	Beroni : Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay fo..	AQ
2020	Beroni Group Limited (nsx : BTG) Successful Completion of SARS-CoV-2 Assay	AQ
2020	Genscript Biotech : Interim report 2020	PU
2020	Genscript Biotech : Inside information and resumption of trading	PU
2020	Genscript Biotech : Trading halt	PU
2020	Genscript Biotech : Announcement of unaudited consolidated interim results for the six mon..	PU
2020	Genscript Biotech : Cayman and GenScript Partner to Offer Neoantigen Profiling and Synthes..	AQ
2020	Beroni Group Limited (nsx : BTG) Signs Agreement with Genscript Biotech	AQ
2020	Genscript Biotech : Voluntary announcement-research and development update	PU
2020	Genscript Biotech : List of directors and their role and function	PU
2020	Genscript Biotech : Change of chief executive officer and redesignation of director	PU
2020	Genscript Biotech : Announces Publication of Clinical Data On New Method for Detecting COV..	PR
2020	Genscript Biotech : TRANSFER OF DISTRIBUTION ADSs AND DESPATCH OF CHEQUES FOR CASH PAYMENT..	PU
2020	Genscript Biotech : Duke-NUS, GenScript and A*STAR launch first-in-the-world SARS-CoV-2 se..	AQ
2020	Genscript Probio : and Eutilex Enter into Exclusive Strategic Collaboration on Plasmid and..	PR
2020	Genscript Biotech : Proposed spin-off of legend biotech corporation	PU
2020	Genscript Biotech : Donates Protective Supplies to Fight Coronavirus, Calls for Greater At..	PR
2019	Genscript Biotech : Voluntary announcement - investment agreement with zhenjiang committee	PU
2019	Genscript Biotech : and Selecxine Enter Into Strategic Cooperation Agreement	PR
2019	Genscript Biotech : China's Largest Plasmid and Virus Facility from GenScript was Put into..	PR
2019	Genscript Biotech : to Host Global Forum on Cell and Gene Therapy and the Booming China Ma..	PR
2019	Genscript Biotech : Next Day Disclosure Return	PU
2019	Genscript Biotech : Voluntary announcement - research and development update	PU
2019	Genscript Biotech : Grant of share options and grant of restricted shares	PU
2019	Genscript Biotech : Voluntary announcement - research and development update	PU
2017	Genscript Biotech : Launches Custom Rabbit Monoclonal Antibody Service	PU
2016	Genscript Biotech : Corporation Finishes Year with Successful Hong Kong IPO	BU

Volgende evenement op GENSCRIPT BIOTECH CORPORATION

24/03/23

Boekjaar 2022 Cijferpublicaties (schatting)

De agenda van het bedrijf

Komende gebeurtenissen in de sector

09/02/23	ALNYLAM PHARMACEUTICALS, INC. : Boekjaar 2022 Cijferpublicaties (schatting)
10/02/23	IQVIA HOLDINGS INC. : Boekjaar 2022 Cijferpublicaties
15/02/23	SEAGEN INC. : Boekjaar 2022 Cijferpublicaties
23/02/23	MODERNA, INC. : Boekjaar 2022 Cijferpublicaties (schatting)

Meer evenementen

Sector

Gezondheidszorg
	Farmaceutisch en medisch onderzoek
		Biotechnologie & Medisch Onderzoek
			Biotechnologie & Medisch Onderzoek
				Biotechnologie & Medisch Onderzoek - Andere